Vanda Pharmaceuticals, Inc.
(NASDAQ : VNDA)

( )
VNDA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.82%132.300.0%$1592.67m
OCGNOcugen, Inc. -14.25%8.970.0%$993.97m
NVAXNovavax, Inc. -13.89%158.1092.9%$973.00m
AMGNAmgen, Inc. -0.91%221.911.3%$586.84m
REGNRegeneron Pharmaceuticals, Inc. 0.59%449.382.7%$521.53m
VRTXVertex Pharmaceuticals, Inc. -0.31%207.791.9%$503.86m
GILDGilead Sciences, Inc. 0.77%63.231.0%$499.99m
ILMNIllumina, Inc. -4.03%399.613.5%$482.11m
BIIBBiogen, Inc. -1.14%263.571.7%$367.21m
ALXNAlexion Pharmaceuticals, Inc. 0.18%148.462.0%$360.83m
CRSPCRISPR Therapeutics AG -3.02%115.490.6%$268.32m
BNGOBioNano Genomics, Inc. -19.30%6.900.0%$265.49m
EXASEXACT Sciences Corp. -4.39%121.0218.4%$224.11m
SGENSeagen Inc. -1.68%145.455.8%$204.38m
VXRTVaxart, Inc. -6.92%5.920.0%$174.35m

Company Profile

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.